|
JSF-3285, A Novel KasA Inhibitor for Tuberculosis
Figure 1. Summary profile of JSF-3285: A) In vitro profile. B) X-ray crystal structure andbinding constant for complex with KasA. C) In vivo profile in mouse chronic infection model.Invention Summary:New antibacterial drugs that treat multidrug resistant mycobacterium tuberculosis (MDR TB) represent an area of high medical need. The current tuberculosis...
Published: 12/8/2021
|
Inventor(s): Joel Freundlich, David Alland, Matthew Neiditch, Glenn Capodagli, Daigo Inoyama, Pradeep Kumar, Divya Awasthi
Keywords(s): Antibacterial
Category(s): Technology Classifications > Healthcare & Life Sciences, Technology Classifications > Therapeutics
|
